PDEX
Price
$61.55
Change
-$1.34 (-2.13%)
Updated
Jul 13 closing price
Capitalization
196.9M
38 days until earnings call
Intraday BUY SELL Signals
PRE
Price
$18.68
Change
+$0.82 (+4.59%)
Updated
Jul 13 closing price
Capitalization
319.27M
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PDEX vs PRE

PDEX vs PRE Comparison Chart in %
View a ticker or compare two or three
VS
PDEX vs. PRE commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDEX is a Hold and PRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (PDEX: $61.55 vs. PRE: $18.68)
Brand notoriety: PDEX and PRE are both not notable
PDEX represents the Pharmaceuticals: Other, while PRE is part of the Food: Major Diversified industry
Current volume relative to the 65-day Moving Average: PDEX: 65% vs. PRE: 35%
Market capitalization -- PDEX: $196.9M vs. PRE: $319.27M
PDEX [@Pharmaceuticals: Other] is valued at $196.9M. PRE’s [@Food: Major Diversified] market capitalization is $319.27M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.19B to $0. The market cap for tickers in the [@Food: Major Diversified] industry ranges from $255.67B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.95B. The average market capitalization across the [@Food: Major Diversified] industry is $3.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDEX’s FA Score shows that 0 FA rating(s) are green whilePRE’s FA Score has 1 green FA rating(s).

  • PDEX’s FA Score: 0 green, 5 red.
  • PRE’s FA Score: 1 green, 4 red.
According to our system of comparison, PDEX is a better buy in the long-term than PRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDEX’s TA Score shows that 4 TA indicator(s) are bullish while PRE’s TA Score has 4 bullish TA indicator(s).

  • PDEX’s TA Score: 4 bullish, 5 bearish.
  • PRE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both PDEX and PRE are a bad buy in the short-term.

Price Growth

PDEX (@Pharmaceuticals: Other) experienced а -0.45% price change this week, while PRE (@Food: Major Diversified) price change was +6.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.

The average weekly price growth across all stocks in the @Food: Major Diversified industry was -1.71%. For the same industry, the average monthly price growth was -7.02%, and the average quarterly price growth was -11.24%.

Reported Earning Dates

PDEX is expected to report earnings on Aug 20, 2026.

PRE is expected to report earnings on Sep 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Food: Major Diversified (-1.71% weekly)

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRE($319M) has a higher market cap than PDEX($197M). PDEX has higher P/E ratio than PRE: PDEX (16.98) vs PRE (1.06). PDEX YTD gains are higher at: 59.953 vs. PRE (18.603). PDEX has higher annual earnings (EBITDA): 18.2M vs. PRE (-58.7M). PRE has more cash in the bank: 23.7M vs. PDEX (11M). PRE has less debt than PDEX: PRE (2.11M) vs PDEX (19.3M). PRE (77.1M) and PDEX (74.6M) have equivalent revenues.
PDEXPREPDEX / PRE
Capitalization197M319M62%
EBITDA18.2M-58.7M-31%
Gain YTD59.95318.603322%
P/E Ratio16.981.061,603%
Revenue74.6M77.1M97%
Total Cash11M23.7M46%
Total Debt19.3M2.11M917%
FUNDAMENTALS RATINGS
PDEX: Fundamental Ratings
PDEX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
50
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDEXPRE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 27 days ago
75%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
57%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
PDEX
Daily Signal:
Gain/Loss:
PRE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMAX49.73N/A
N/A
MFS Emerging Markets Equity A
RGCEX18.09N/A
N/A
Columbia Select Global Equity C
TNBIX21.23N/A
N/A
1290 SmartBeta Equity I
TEGCX19.38N/A
N/A
Touchstone Sands Cptl Emerg Mkts Gr C
ACWZX21.38N/A
N/A
AMG GW&K Small/Mid Cap Growth Z

PDEX and

Correlation & Price change

A.I.dvisor tells us that PDEX and TCMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and TCMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-2.13%
TCMD - PDEX
24%
Poorly correlated
-2.65%
PRE - PDEX
23%
Poorly correlated
+4.59%
WAT - PDEX
23%
Poorly correlated
-0.85%
GKOS - PDEX
23%
Poorly correlated
N/A
ZBH - PDEX
22%
Poorly correlated
+3.00%
More